Clinical Trial Update: Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating palifermin to reduce acute graft-versus-host disease in patients with hematologic malignancies undergoing allogeneic marrow/peripheral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematologic Malignancies

Drugs mentioned

• Palifermin (palifermin)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Graft Versus Host Disease, Hematologic Malignancies | Phase 2 | Status: COMPLETED | Results posted: 2014-09-15